The region includes nine science parks, hosting a diverse range of bioscience companies, creating what is arguably the largest and fastest growing Biotech cluster in the UK
DiagnOx is situated near Bicester in the Heyford Park business park and comprises serviced laboratories and offices focused on the needs of early stage R & D based diagnostics companies. It is run through Oxford Innovation who also runs a number of innovation centres across Oxfordshire. DiagnOx provides, in addition to lab and office space, access to finance and mentoring programmes, which can be accessed by the tenant companies
The Oxford BioEscalator being constructed on the Churchill hospital site in Headington, Oxford will pioneer a new model to support spinouts and start-ups effectively and economically, enabling them to grow into leading mid-sized biosciences businesses
A new biotechnology incubator will be opening on the Milton Park Estate, near Didcot in South Oxfordshire in 2015. The development will cater for small and growing businesses within the life sciences sector
Harwell Science and Innovation Campus includes the only UK synchrotron (the Diamond Light Source), which has accelerated advances in the both fields of structural biology and in the use of infrared spectroscopy to establish markers for drug action and biomarkers for cancer
The University of Reading Science Park provides a mix of offices and laboratories for corporate R&D and early stage businesses, combined with specialist services and networks into the University and more widely
Begbroke Science Park is located five miles north of Oxford, England. It is owned and managed by Oxford University
The Oxford Radcliffe Biobank (ORB) and Oxford Centre for Histopathology Research (OCHRe) currently holds over 160,000 biosamples and associated data from across the University of Oxford. Tissue collection is undertaken for a variety of research purposes and, where possible, diseased and normal samples are collected from each patient. Various formats of samples are collected, including fresh-frozen and paraffin-embedded. Basic anonymised data sets are supplied, including gender, age at time of operation and histological diagnosis.
The Oxford Biobank has been in place since 2000 covering 'Collection of blood and fat samples from a healthy Oxfordshire population for generic and physiological research'. Its main purpose is to create a bioresource for translational research with the specific aim to perform research into functional properties of common variants of genes involved in diabetes, obesity and heart disease.
UK Biobank is a major national health resource, and a registered charity in its own right, with the aim of improving the prevention, diagnosis and treatment of a wide range of serious and life-threatening illnesses. UK Biobank recruited 500,000 people aged between 40-69 years in 2006-2010 from across the country to take part in this project.
The University of Oxford is home to 6 UK Clinical Research Collaborative (UKCRC)-certified clinical trials units (CTUs), specialist units set up with the specific remit to design, conduct, analyse and publish clinical trials and other well-designed studies. The University’s centralised Clinical Trials and Research Governance (CTRG) team provides advice and support. All 6 clinical trials units and the Oxford Biomedical Research Centre provide expertise in the acquisition, storage and analysis of patient samples for research and development
The Oxford AHSN and AHSC have close links with other regional hospitals, including Milton Keynes, High Wycombe, Gloucester, Stoke Mandeville, Reading, and are regularly liaising with colleagues from those centres, including recruiting patients from those centres to our research studies. We have multiple collaborations with all other comprehensive NIHR-BRC centres (Imperial, UCL, Cambridge, Guys and St Thomas)
The Thames Valley and South Midlands CRN is hosted by Oxford University Hospitals NHS Foundation Trust (OUH) and works with OUH to ensure the effective delivery of research in the Trusts, primary care organisations and other qualified NHS providers throughout the Thames Valley and South Midlands area
Located in Headington, the Clinical BioManufacturing Facility is the University of Oxford’s GMP (Good Manufacturing Practice) manufacturing facility, having over 18 years’ experience in producing biological Investigational Medicinal Products (IMPs) according to the principles of GMP for early phase clinical trials
Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the protection of individuals with regard to the processing of personal data and on the free movement of such data
How to conform with the legal requirements for placing medical devices on the market
The Health Apps Library, was launched as a pilot site in 2013 to review and recommend apps against a defined set of criteria